Linezolid Zentiva (Linezolid)

Linezolid blocks bacterial protein synthesis by binding to the 50S ribosomal subunit. This prevents the formation of the initiation complex required for translation, halting production of essential proteins and resulting in a bacteriostatic effect against susceptible Gram‑positive organisms.

The prescribing clinician determines the exact regimen based on the infection type and patient factors. In many adult cases, linezolid is commonly prescribed as 600 mg taken orally twice daily for a typical course of 10–14 days, but the final dose and duration must be individualized by the healthcare provider.

Safety data for linezolid in pregnancy and lactation are limited, and the product does not have a definitive category. It should be used only when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Linezolid is often compared with vancomycin, another agent for resistant Gram‑positive infections. While vancomycin is administered intravenously and can cause nephrotoxicity, linezolid offers oral bioavailability, simplifying outpatient treatment, but carries a higher risk of hematologic toxicity and serotonin syndrome when combined with serotonergic drugs.

Linezolid Zentiva should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

The medication is supplied as oral tablets that are swallowed whole with or without food. Patients should follow the prescriber’s instructions regarding timing and duration, and avoid crushing or chewing the tablets unless specifically directed.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, optic neuropathy, serotonin syndrome when combined with serotonergic agents, and lactic acidosis. Patients should report unusual bleeding, persistent fatigue, visual changes, or symptoms of serotonin excess such as agitation, hyperthermia, or tremor to their healthcare provider promptly.

Linezolid should be avoided in individuals with known hypersensitivity to linezolid or other oxazolidinones. It is contraindicated in patients currently receiving monoamine oxidase inhibitors or other serotonergic drugs due to the risk of serotonin syndrome, and should be used with caution in pregnant or breastfeeding women, the elderly, and those with pre‑existing blood‑cell abnormalities.